Drug
Acetylcysteine
Acetylcysteine: highest development phase Phase 3, developed by Sandoz. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| acetylcysteine NCT04123405 | Phase 3 | Rhinosinusitis |
| Acetylcysteine NCT05070650 | Phase 3 | Common Cold |
Latest
No recent events.
Follow Acetylcysteine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.